John Fung to Dendritic Cells
This is a "connection" page, showing publications John Fung has written about Dendritic Cells.
Connection Strength
1.716
-
All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function. J Immunol. 2014 Jun 01; 192(11):5098-108.
Score: 0.090
-
The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood. 2013 Mar 07; 121(10):1760-8.
Score: 0.082
-
The role of liver stromal cells in dendritic cells development in mice. Transplant Proc. 2010 Dec; 42(10):4279-81.
Score: 0.071
-
Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27. J Hepatol. 2009 Sep; 51(3):510-9.
Score: 0.064
-
Growth factor-induced mobilization of dendritic cells in kidney and liver of rhesus macaques: implications for transplantation. Transplantation. 2007 Mar 15; 83(5):656-62.
Score: 0.055
-
The role of liver-derived regulatory dendritic cells in prevention of type 1 diabetes. Immunology. 2007 Feb; 120(2):251-60.
Score: 0.054
-
Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells. Transplant Proc. 2007 Jan-Feb; 39(1):281-2.
Score: 0.054
-
In vivo expansion of two distinct dendritic cells in mouse livers and its impact on liver immune regulation. Liver Transpl. 2006 Dec; 12(12):1850-61.
Score: 0.054
-
Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. J Heart Lung Transplant. 2006 Mar; 25(3):310-9.
Score: 0.051
-
Regulatory dendritic cells modulate immune responses via induction of T-cell apoptotic death. Microsurgery. 2006; 26(1):21-4.
Score: 0.051
-
Immune regulatory activity of liver-derived dendritic cells generated in vivo. Microsurgery. 2006; 26(1):17-20.
Score: 0.051
-
Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization. J Cancer Res Clin Oncol. 2005 Jul; 131(7):429-38.
Score: 0.048
-
Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity. Ann Surg. 2005 Mar; 241(3):497-505.
Score: 0.048
-
Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation. 2005 Feb 27; 79(4):451-9.
Score: 0.048
-
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness. Transplant Proc. 2004 Jun; 36(5):1592-4.
Score: 0.045
-
Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway. J Immunol. 2004 Feb 01; 172(3):1355-63.
Score: 0.044
-
Ex vivo priming of naïve T cells into EBV-specific Th1/Tc1 effector cells by mature autologous DC loaded with apoptotic/necrotic LCL. Am J Transplant. 2003 Nov; 3(11):1369-77.
Score: 0.043
-
Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
Score: 0.043
-
Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes. 2003 Aug; 52(8):1976-85.
Score: 0.043
-
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol. 2002 Sep 15; 169(6):3382-91.
Score: 0.040
-
Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol. 2002 Aug; 104(2):138-50.
Score: 0.040
-
Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function. Transplant Proc. 2002 Aug; 34(5):1394-5.
Score: 0.040
-
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses. J Immunol. 2001 Jun 15; 166(12):7042-52.
Score: 0.037
-
Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Transplant Proc. 2001 Feb-Mar; 33(1-2):235.
Score: 0.036
-
Use of autologous dendritic cells loaded with apoptotic LCL for ex vivo generation of specific CTL from the PBMC of EBV(-) individuals. Transplant Proc. 2001 Feb-Mar; 33(1-2):441.
Score: 0.036
-
Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model. Cell Transplant. 2001; 10(3):343-50.
Score: 0.036
-
Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection. Immunology. 2000 Oct; 101(2):233-41.
Score: 0.035
-
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther. 2000 May; 1(5 Pt 1):430-7.
Score: 0.034
-
Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity. Transplant Proc. 1999 Feb-Mar; 31(1-2):797.
Score: 0.031
-
Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1. Transplant Proc. 1999 Feb-Mar; 31(1-2):1195.
Score: 0.031
-
Tolerance and chimerism in liver transplantation. Transplant Proc. 1997 Nov; 29(7):2817-8.
Score: 0.029
-
Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin. Transplant Proc. 1997 Jun; 29(4):2175-6.
Score: 0.028
-
Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts. Transplant Proc. 1997 Feb-Mar; 29(1-2):1310.
Score: 0.027
-
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation. 1996 Sep 15; 62(5):659-65.
Score: 0.027
-
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med. 1995 Aug 01; 182(2):379-87.
Score: 0.025
-
In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation. Transplantation. 1995 Feb 27; 59(4):544-51.
Score: 0.024
-
A simplified method for growing dendritic cells from rat bone marrow. Adv Exp Med Biol. 1995; 378:53-5.
Score: 0.024
-
Dendritic cell replacement in long-surviving liver and cardiac xenografts. Transplantation. 1993 Aug; 56(2):482-4.
Score: 0.021
-
A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection. Microsurgery. 2010 May; 30(4):332-7.
Score: 0.017
-
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2004 Dec; 40(6):1312-21.
Score: 0.012
-
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation. 2001 Oct 27; 72(8 Suppl):S13-22.
Score: 0.009
-
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses. Transplant Proc. 2001 Feb-Mar; 33(1-2):525.
Score: 0.009
-
Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation. 1999 Sep 27; 68(6):747-57.
Score: 0.008
-
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation. 1998 Jun 27; 65(12):1590-8.
Score: 0.008
-
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation. 1997 Dec 27; 64(12):1808-15.
Score: 0.007
-
An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol. 1997; 417:269-74.
Score: 0.007